James Howells lost $800 million in bitcoin to a landfill. Now, his relentless quest to recover it is a wild mix of tech, ...
UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback